Royal Bank of Canada’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Buy |
1,679,810
+1,669,543
| +16,261% | +$18.8M | ﹤0.01% | 1425 |
|
|
2025
Q1 | $104K | Sell |
10,267
-17,726
| -63% | -$180K | ﹤0.01% | 4837 |
|
|
2024
Q4 | $332K | Sell |
27,993
-3,179
| -10% | -$37.7K | ﹤0.01% | 3963 |
|
|
2024
Q3 | $360K | Sell |
31,172
-4,721
| -13% | -$54.5K | ﹤0.01% | 3942 |
|
|
2024
Q2 | $380K | Buy |
35,893
+30,954
| +627% | +$328K | ﹤0.01% | 3864 |
|
|
2024
Q1 | $52K | Sell |
4,939
-79,914
| -94% | -$841K | ﹤0.01% | 5087 |
|
|
2023
Q4 | $953K | Buy |
84,853
+79,747
| +1,562% | +$896K | ﹤0.01% | 3223 |
|
|
2023
Q3 | $60K | Buy |
5,106
+896
| +21% | +$10.5K | ﹤0.01% | 5202 |
|
|
2023
Q2 | $43K | Buy |
4,210
+4,037
| +2,334% | +$41.2K | ﹤0.01% | 5392 |
|
|
2023
Q1 | $1K | Sell |
173
-669
| -79% | -$3.87K | ﹤0.01% | 6534 |
|
|
2022
Q4 | $7K | Buy |
+842
| New | +$7K | ﹤0.01% | 6190 |
|
|
2022
Q2 | – | Sell |
-6,065
| Closed | -$30K | – | 7096 |
|
|
2022
Q1 | $30K | Buy |
6,065
+6,055
| +60,550% | +$30K | ﹤0.01% | 5896 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 7228 |
|